Efficient Retrograde Neuronal Transduction Utilizing Self-complementary AAV1
Open Access
- 1 February 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (2) , 296-301
- https://doi.org/10.1038/sj.mt.6300367
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Efficiency of eight different AAV serotypes in transducing rat myocardium in vivoGene Therapy, 2007
- Treatment of human disease by adeno-associated viral gene transferHuman Genetics, 2006
- Intramuscular viral delivery of paraplegin rescues peripheral axonopathy in a model of hereditary spastic paraplegiaJournal of Clinical Investigation, 2005
- Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiencyThe Journal of Gene Medicine, 2005
- Enhancing rAAV vector expression in the lungThe Journal of Gene Medicine, 2005
- Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous SystemMolecular Therapy, 2004
- Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivoGene Therapy, 2003
- Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brainGene Therapy, 2003
- Characterization of Tissue Tropism Determinants of Adeno-Associated Virus Type 1Journal of Virology, 2003
- Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesisGene Therapy, 2001